Clinical Trial Update: Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy

View source ↗

Summary

A Viome-sponsored clinical trial is investigating how the gut microbiome influences responses to immunotherapy in gynecologic cancer patients. Recruitment is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer

Snippet

Sponsor: Viome | Conditions: Gynecologic Cancer, Immunotherapy | Status: RECRUITING